John Hancock and MIT AgeLab collaborate to research and enhance longevity – Insurance News

0
59

John Hancock Partners with MIT AgeLab to Explore Longevity Innovation and Wellness Programs

John Hancock, a leader in wellness programs for policyholders, has announced a groundbreaking collaboration with the Massachusetts Institute of Technology’s AgeLab. This five-year, multimillion dollar partnership aims to explore longevity innovation and drive actionable insights for the business community, policyholders, individuals, and families.

The collaboration aligns with John Hancock’s commitment to empowering the sustained health and wellbeing of their customers through programs like “Vitality.” CEO Brooks Tingle emphasized the company’s dedication to helping policyholders live longer and healthier lives, as it ultimately reduces claims and increases retirement savings.

With the world’s aging population expected to double by 2050, the need for solutions to address the longevity crisis is urgent. MIT AgeLab founder Dr. Joseph Coughlin highlighted the multifaceted nature of aging, describing it as a medical, engineering, technology, and financial problem. The collaboration with John Hancock will introduce a longevity preparedness index to measure Americans’ readiness to live longer, healthier lives and provide insights for financial planning, health and wellness habits, and more.

During a tour of the AgeLab, high-tech tools and toys were showcased to demonstrate how technology can enable older individuals to stay in their homes longer. From automobile simulators to home devices that monitor health and provide entertainment, the focus is on creating a platform of services that support aging in place.

Coughlin emphasized the increasing demand for subscription and technology services that promote healthy behaviors and provide support in various aspects of daily life. This shift towards a “life by app” model introduces a new line item in retirement planning, highlighting the importance of incorporating technology into aging strategies.

As the collaboration progresses, John Hancock aims to have a global understanding of the longevity ecosystem, starting in Boston as a hub for longevity innovation. The ultimate goal is to leverage insights from the partnership to benefit customers and organizations across sectors.

In conclusion, the collaboration between John Hancock and MIT AgeLab represents a significant step towards addressing the challenges of an aging population and promoting healthier, longer lives for individuals worldwide.